CDC and partners ensure rapid and coordinated surveillance, detection, and response to hepatitis outbreaks.
Upon consultation CDC can provide assistance to health departments during investigation, and share best practices based on many states’ previous experiences with issues such as: infection control breaches previously associated with transmissions in specific settings and observation recommendations, guidance for notification messages including specific populations to screen, and guidance on laboratory testing and molecular genetic investigation.
This manuscript suggests an approach to follow-up of infection control breaches that focuses on the risk of bloodborne pathogen transmission.
Healthcare Investigation GuideRecommended steps for investigating single cases of HBV or HCV suspected to be related to healthcare delivery
Healthcare Notification and Testing ToolkitFramework for use by health departments for public notification in response to possible bloodborne pathogen exposures
Hepatitis in young injection drug users
The highest reported incidence of acute hepatitis C in the United States is now among persons aged 20–29 years. In recent years, there has been an emerging HCV epidemic among young PWIDs, particularly in rural and suburban settings. Further reading.
Hepatitis A Outbreaks
Reporting HBV and HCV infections among repeat blood donors
- Page last reviewed: August 19, 2015
- Page last updated: August 19, 2015
- Content source: